Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial

Fahimeh Firouz, Faeghe Sheikhalizadeh Nobar, Hossein Azizi

Open source

DOI
10.1016/j.medcli.2026.107662
Published
2026-10
Container
Medicina Clínica
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.medcli.2026.107662,
  title = {Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial},
  author = {Fahimeh Firouz and Faeghe Sheikhalizadeh Nobar and Hossein Azizi},
  year = {2026},
  journal = {Medicina Clínica},
  doi = {10.1016/j.medcli.2026.107662},
  url = {https://doi.org/10.1016/j.medcli.2026.107662}
}

RIS

TY  - JOUR
TI  - Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial
AU  - Fahimeh Firouz
AU  - Faeghe Sheikhalizadeh Nobar
AU  - Hossein Azizi
PY  - 2026
JO  - Medicina Clínica
DO  - 10.1016/j.medcli.2026.107662
UR  - https://doi.org/10.1016/j.medcli.2026.107662
ER  - 

APA

Firouz, F., Nobar, F. S., & Azizi, H. (2026). Efficacy of adjuvant intralesional rituximab in patients with pemphigus vulgaris and oral lesions receiving systemic rituximab: A randomized controlled pilot trial. Medicina Clínica. https://doi.org/10.1016/j.medcli.2026.107662

Source records